Development and evaluation of sustained-release Compritol^® 888 ATO matrix mini-tablets

References

• Kachrimanis K, Petrides M, Malamataris S. (2005). Flow rate of some pharmaceutical diluents through die-orifices relevant to mini-tableting. Int J Pharm, 303:72–80.
   PubMed Web of Science ®Google Scholar
• Flemming J, Mielck JB. (1995) Requirements for the production of microtablets - suitability of direct-compression excipients estimated from powder characteristics and flow-rates. Drug Dev Ind Pharm, 21:2239–2251.
   Web of Science ®Google Scholar
• Lennartz P, Mielck JB. (1998) Minitabletting: improving the compactability of paracetamol powder mixtures. Int J Pharm, 173:75–85.
   Web of Science ®Google Scholar
• Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG. (2009). Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics, 123:e235–e238.
   PubMed Web of Science ®Google Scholar
• Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. (2007). Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol, 59:1043–1055.
   PubMed Web of Science ®Google Scholar
• Lopes CM, Sousa Lobo JM, Costa P, Pinto JF. (2006). Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release. Drug Dev Ind Pharm, 32:95–106.
   PubMed Web of Science ®Google Scholar
• Lopes CM, Lobo JM, Pinto JF, Costa P. (2006). Compressed mini-tablets as a biphasic delivery system. Int J Pharm, 323:93–100.
   PubMed Web of Science ®Google Scholar
• Ozyazici M, Gökçe EH, Ertan G. (2006). Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm, 63:331–339.
   PubMed Web of Science ®Google Scholar
• Jannin V, Bérard V, N’Diaye A, Andrès C, Pourcelot Y. (2003). Comparative study of the lubricant performance of Compritol 888 ATO either used by blending or by hot melt coating. Int J Pharm, 262:39–45.
   PubMed Web of Science ®Google Scholar
• N’Diaye A, Jannin V, Bérard V, Andrès C, Pourcelot Y. (2003). Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. Int J Pharm, 254:263–269.
   PubMed Web of Science ®Google Scholar
• Barthelemy P, Laforêt JP, Farah N, Joachim J. (1999). Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations. Eur J Pharm Biopharm, 47:87–90.
   PubMed Web of Science ®Google Scholar
• Faham A, Prinderre P, Farah N, Eichler KD, Kalantzis G, Joachim J. (2000). Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. Drug Dev Ind Pharm, 26:167–176.
   PubMed Web of Science ®Google Scholar
• Hamdani J, Moës AJ, Amighi K. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int J Pharm, 245:167–177.
   PubMed Web of Science ®Google Scholar
• Hamdani J, Moës AJ, Amighi K. (2006). Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. Int J Pharm, 322:96–103.
   PubMed Web of Science ®Google Scholar
• Gu X, Fediuk DJ, Simons FE, Simons KJ. (2004). Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. Drug Dev Ind Pharm, 30:1009–1017.
   PubMed Web of Science ®Google Scholar
• Li FQ, Hu JH, Deng JX, Su H, Xu S, Liu JY. (2006). In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm, 324:152–157.
   PubMed Web of Science ®Google Scholar
• Obaidat AA, Obaidat RM. (2001). Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur J Pharm Biopharm, 52:231–235.
   PubMed Web of Science ®Google Scholar
• Rao MR, Ranpise AA, Thanki KC, Borate SG, Parikh GN. (2009). Effect of processing and sintering on controlled release wax matrix tablets of ketorolac tromethamine. Indian J Pharm Sci, 71:538–544.
   PubMed Web of Science ®Google Scholar
• Zhang YE, Schwartz JB. (2000). Effect of diluents on tablet integrity and controlled drug release. Drug Dev Ind Pharm, 26:761–765.
   PubMed Web of Science ®Google Scholar
• Zhang YE, Schwartz JB. (2003). Melt granulation and heat treatment for wax matrix-controlled drug release. Drug Dev Ind Pharm, 29:131–138.
   PubMed Web of Science ®Google Scholar
• Zhang YE, Tchao R, Schwartz JB. (2001). Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release. Pharm Dev Technol, 6:131–144.
   PubMed Web of Science ®Google Scholar
• Munday DL, Fassihi AR. (1989) Controlled release delivery: effect of coating composition on release characteristics of mini-tablets. Int J Pharm, 52:109–114.
   Web of Science ®Google Scholar
• Treanor G, Roberts M, Mostafa S, Miolane C. (2010) Diluent effects on drug release from sustained-release Compritol® 888 ATO tablets. J Pharm Pharmacol, 62:1419–1420.
   Web of Science ®Google Scholar
• Munday DL. (1994) A comparison of the dissolution characteristics of theophylline from film coated granules and mini-tablets. Drug Dev Ind Pharm, 20:2369–2379.
   Web of Science ®Google Scholar
• Bodea M, Tomuta I, Leucuta S. (2010) Identification of critical formulation variables for obtaining metoprolol tartrate mini-tablets. Farmacia, 58:719–727.
   Web of Science ®Google Scholar
• Fujicalin® product information. Available at: http://www.fujicalin.com/product/index.php. Accessed on 06 June 2011.
   Google Scholar
• Lactopress® spray-dried product information. Available at: http://www.domo-pharma.com/products/lactopress.aspx. Accessed on 06 June 2011.
   Google Scholar
• Fell JT, Newton JM. (1968) The tensile strength of lactose tablets. J Pharm Pharmacol, 20:657–659.
   PubMed Web of Science ®Google Scholar
• Doldán C, Souto C, Concheiro A, Martínez-Pacheco R, Gómez-Amoza JL. (1995) Dicalcium phosphate dihydrate and anhydrous dicalcium phosphate for direct compression: A comparative study. Int J Pharm, 124:69–74.
   Web of Science ®Google Scholar
• Schlack H, Bauer-Brandl A, Schubert R, Becker D. (2001). Properties of fujicalin, a new modified anhydrous dibasic calcium phosphate for direct compression: comparison with dicalcium phosphate dihydrate. Drug Dev Ind Pharm, 27:789–801.
   PubMed Web of Science ®Google Scholar
• Hamza Yel-S, Aburahma MH. (2010). Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. Drug Dev Ind Pharm, 36:337–349.
   PubMed Web of Science ®Google Scholar